{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:14683"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:14683","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"The direct and indirect effects of attenuated salmonella typhimurium on intestinal tumour epithelium","abstract":"Attenuated Salmonella enterica serovar typhimurium (STm) home to and colonise tumours, where it can induce tumour regression. In this thesis I aimed to identify how STm invade tumour cells and to what extent intracellular invasion is necessary for anti-tumour response. Bulk and single-cell RNA-sequencing were utilised to reveal differences between invasive versus extracellular-restricted Salmonella. ApcMin/+ mice were treated with Salmonella that are invasion-sufficient or extracellular-restricted, then innate immune infiltrate and polyp burden were assessed. I used in vitro models to show that STm preferentially invades proliferating cells in patient and murine tumour organoids. Invasion of tumour cells was dependent on Salmonella binding host cell cholesterol via SipB expression. Previous studies have shown that cell-surface cholesterol is maximal during mitosis, thus I show mechanistic insight into why proliferating cells are preferentially targeted. STmΔaroA induce similar transcriptional changes in both mouse and human tumour organoids in vitro when restricted to the extracellular space or permitted to invade. I generated and validated a strain of STm which cannot invade intracellularly, STmΔaroAΔsipB, but I show with oral gavage of ApcMin/+ mice that this mutant can colonise the polyp environment in vivo. This extracellular survival resulted in similar innate cell recruitment but led to superior clearance of polyps, which warrants further investigation. In summary, STm specifically infects proliferating tumour cells via binding of cell surface cholesterol, which has implications for utilisation of bacteria as intracellular drug delivery systems. Intracellular invasion appears to be dispensable for the therapeutic effect, as we see reduction of polyps with STmΔaroAΔsipB; this double mutant may then represent a superior and safer bacterial cancer therapy agent.","abstract_html":"Attenuated Salmonella enterica serovar typhimurium (STm) home to and colonise tumours, where it can induce tumour regression. In this thesis I aimed to identify how STm invade tumour cells and to what extent intracellular invasion is necessary for anti-tumour response. Bulk and single-cell RNA-sequencing were utilised to reveal differences between invasive versus extracellular-restricted Salmonella. ApcMin/+ mice were treated with Salmonella that are invasion-sufficient or extracellular-restricted, then innate immune infiltrate and polyp burden were assessed. I used in vitro models to show that STm preferentially invades proliferating cells in patient and murine tumour organoids. Invasion of tumour cells was dependent on Salmonella binding host cell cholesterol via SipB expression. Previous studies have shown that cell-surface cholesterol is maximal during mitosis, thus I show mechanistic insight into why proliferating cells are preferentially targeted. STmΔaroA induce similar transcriptional changes in both mouse and human tumour organoids in vitro when restricted to the extracellular space or permitted to invade. I generated and validated a strain of STm which cannot invade intracellularly, STmΔaroAΔsipB, but I show with oral gavage of ApcMin/+ mice that this mutant can colonise the polyp environment in vivo. This extracellular survival resulted in similar innate cell recruitment but led to superior clearance of polyps, which warrants further investigation. In summary, STm specifically infects proliferating tumour cells via binding of cell surface cholesterol, which has implications for utilisation of bacteria as intracellular drug delivery systems. Intracellular invasion appears to be dispensable for the therapeutic effect, as we see reduction of polyps with STmΔaroAΔsipB; this double mutant may then represent a superior and safer bacterial cancer therapy agent.","abstract_has_math":false,"creators":["Mackie, Gillian M"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024-07","date_published":"2024-07","updated_at":"2026-11-21T09:53:45Z","subjects":["QR Microbiology","QR180 Immunology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"person:identifier.orcid","label":"ORCID","values":["0000000177586570"],"render_values":[{"text":"0000-0001-7758-6570","href":"https://orcid.org/0000-0001-7758-6570","code":true}]}]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"https://etheses.bham.ac.uk/id/eprint/14683/13/Mackie2024PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A14683","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["cancer_research_uk"]},{"key":"dc:creator","label":"Author","values":["Mackie, Gillian M"]},{"key":"person:identifier.orcid","label":"ORCID","values":["0000000177586570"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2024-07-19"]},{"key":"dc:date.issued","label":"Date","values":["2024-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Immunology & Immunotherapy"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://etheses.bham.ac.uk/id/eprint/14683/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QR Microbiology","QR180 Immunology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://etheses.bham.ac.uk/id/eprint/14683/13/Mackie2024PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Attenuated Salmonella enterica serovar typhimurium (STm) home to and colonise tumours, where it can induce tumour regression. In this thesis I aimed to identify how STm invade tumour cells and to what extent intracellular invasion is necessary for anti-tumour response. Bulk and single-cell RNA-sequencing were utilised to reveal differences between invasive versus extracellular-restricted Salmonella. ApcMin/+ mice were treated with Salmonella that are invasion-sufficient or extracellular-restricted, then innate immune infiltrate and polyp burden were assessed. I used in vitro models to show that STm preferentially invades proliferating cells in patient and murine tumour organoids. Invasion of tumour cells was dependent on Salmonella binding host cell cholesterol via SipB expression. Previous studies have shown that cell-surface cholesterol is maximal during mitosis, thus I show mechanistic insight into why proliferating cells are preferentially targeted. STmΔaroA induce similar transcriptional changes in both mouse and human tumour organoids in vitro when restricted to the extracellular space or permitted to invade. I generated and validated a strain of STm which cannot invade intracellularly, STmΔaroAΔsipB, but I show with oral gavage of ApcMin/+ mice that this mutant can colonise the polyp environment in vivo. This extracellular survival resulted in similar innate cell recruitment but led to superior clearance of polyps, which warrants further investigation. In summary, STm specifically infects proliferating tumour cells via binding of cell surface cholesterol, which has implications for utilisation of bacteria as intracellular drug delivery systems. Intracellular invasion appears to be dispensable for the therapeutic effect, as we see reduction of polyps with STmΔaroAΔsipB; this double mutant may then represent a superior and safer bacterial cancer therapy agent."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["The direct and indirect effects of attenuated salmonella typhimurium on intestinal tumour epithelium"]}]}],"canonical_facts":{"dc:contributor.sponsor":["cancer_research_uk"],"dc:creator":["Mackie, Gillian M"],"dc:date":["2024-07-19"],"dc:date.issued":["2024-07"],"dc:description.abstract":["Attenuated Salmonella enterica serovar typhimurium (STm) home to and colonise tumours, where it can induce tumour regression. In this thesis I aimed to identify how STm invade tumour cells and to what extent intracellular invasion is necessary for anti-tumour response. Bulk and single-cell RNA-sequencing were utilised to reveal differences between invasive versus extracellular-restricted Salmonella. ApcMin/+ mice were treated with Salmonella that are invasion-sufficient or extracellular-restricted, then innate immune infiltrate and polyp burden were assessed. I used in vitro models to show that STm preferentially invades proliferating cells in patient and murine tumour organoids. Invasion of tumour cells was dependent on Salmonella binding host cell cholesterol via SipB expression. Previous studies have shown that cell-surface cholesterol is maximal during mitosis, thus I show mechanistic insight into why proliferating cells are preferentially targeted. STmΔaroA induce similar transcriptional changes in both mouse and human tumour organoids in vitro when restricted to the extracellular space or permitted to invade. I generated and validated a strain of STm which cannot invade intracellularly, STmΔaroAΔsipB, but I show with oral gavage of ApcMin/+ mice that this mutant can colonise the polyp environment in vivo. This extracellular survival resulted in similar innate cell recruitment but led to superior clearance of polyps, which warrants further investigation. In summary, STm specifically infects proliferating tumour cells via binding of cell surface cholesterol, which has implications for utilisation of bacteria as intracellular drug delivery systems. Intracellular invasion appears to be dispensable for the therapeutic effect, as we see reduction of polyps with STmΔaroAΔsipB; this double mutant may then represent a superior and safer bacterial cancer therapy agent."],"dc:format":["text"],"dc:identifier.uri":["https://etheses.bham.ac.uk/id/eprint/14683/13/Mackie2024PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Immunology & Immunotherapy"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["https://etheses.bham.ac.uk/id/eprint/14683/"],"dc:subject":["QR Microbiology","QR180 Immunology"],"dcterms:accessrights":["public"],"dc:title":["The direct and indirect effects of attenuated salmonella typhimurium on intestinal tumour epithelium"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"],"person:identifier.orcid":["0000000177586570"]},"updated_at":"2026-11-21T09:53:45Z"}